Drupal.behaviors.print = function(context) {window.print();window.close();}>
Atossa Inks Deal for MASCT System; Buys Assets of Intraductal Dx, Therapy Firm
October 04, 2012
Atossa Inks Deal for MASCT System; Buys Assets of Intraductal Dx, Therapy Firm
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Atossa Inks Deal with PPO for Breast Cancer Tests
March 13, 2013 / GenomeWeb Daily News
Atossa Inks Agreement with MultiPlan for Access to Breast Cancer Tests
September 17, 2012 / GenomeWeb Daily News
With IPO Planned, Atossa Posts Revenues of $1,500 for FY 2011
April 9, 2012 / GenomeWeb Daily News
MDx Firm Atossa Genetics Raises $6.6M
June 27, 2011 / GenomeWeb Daily News
Atossa Genetics, HLB Sign Manufacturing Deal
May 3, 2011 / GenomeWeb Daily News